Cargando…

Microbiota Dysbiosis in Parkinson Disease—In Search of a Biomarker

Numerous studies have highlighted the role of the gastrointestinal system in Parkinson disease pathogenesis. It is likely triggered by proinflammatory markers produced by specific gut bacteria. This review’s aim is to identify gut bacterial biomarkers of Parkinson disease. A comprehensive search for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nowak, Julia Maya, Kopczyński, Mateusz, Friedman, Andrzej, Koziorowski, Dariusz, Figura, Monika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495927/ https://www.ncbi.nlm.nih.gov/pubmed/36140158 http://dx.doi.org/10.3390/biomedicines10092057

Ejemplares similares

Mechanisms of Neurodegeneration in Various Forms of Parkinsonism—Similarities and Differences
por: Koziorowski, Dariusz, et al.
Publicado: (2021)

Proteomic Profile of Saliva in Parkinson’s Disease Patients: A Proof of Concept Study
por: Figura, Monika, et al.
Publicado: (2021)

Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders
por: Kowalska‐Taczanowska, Renata, et al.
Publicado: (2020)

Serum amino acid profile in patients with Parkinson’s disease
por: Figura, Monika, et al.
Publicado: (2018)

The Neuromodulatory Impact of Subthalamic Nucleus Deep Brain Stimulation on Gait and Postural Instability in Parkinson's Disease Patients: A Prospective Case Controlled Study
por: Szlufik, Stanislaw, et al.
Publicado: (2018)

Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)
por: Alster, Piotr, et al.
Publicado: (2020)

Gut Microbiota Dysbiosis in Diabetic Retinopathy—Current Knowledge and Future Therapeutic Targets
por: Serban, Dragos, et al.
Publicado: (2023)

Influence of Bilateral Subthalamic Nucleus Deep Brain Stimulation on the Lipid Profile in Patients With Parkinson's Disease
por: Samborska-Ćwik, Joanna, et al.
Publicado: (2020)

Blood Stream Microbiota Dysbiosis Establishing New Research Standards in Cardio-Metabolic Diseases, A Meta-Analysis Study
por: Ullah Goraya, Mohsan, et al.
Publicado: (2023)

Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson’s disease
por: Turski, Paweł, et al.
Publicado: (2022)

A Multimodal Approach to the Quantification of Kinetic Tremor in Parkinson’s Disease
por: Szumilas, Mateusz, et al.
Publicado: (2019)

Parkinson’s Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation
por: Dutta, Sudhir K, et al.
Publicado: (2019)

Deep nasal sinus cavity microbiota dysbiosis in Parkinson’s disease
por: Pal, Gian, et al.
Publicado: (2021)

Gut Microbiota and Its Repercussion in Parkinson’s Disease: A Systematic Review in Occidental Patients
por: Proano, Ana Cristina, et al.
Publicado: (2023)

Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease
por: Li, Peipei, et al.
Publicado: (2021)

Precision Medicine on the Effects of Microbiota on Head–Neck Diseases and Biomarkers Diagnosis
por: Inchingolo, Angelo Michele, et al.
Publicado: (2023)

Role of Helicobacter pylori and Other Environmental Factors in the Development of Gastric Dysbiosis
por: Gomez-Ramirez, Uriel, et al.
Publicado: (2021)

The Influence of Serum Uric Acid Level on Non-Motor Symptoms Occurrence and Severity in Patients with Idiopathic Parkinson’s Disease and Atypical Parkinsonisms—A Systematic Review
por: Grażyńska, Anna, et al.
Publicado: (2021)

Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)

Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases
por: Belvoncikova, Paulina, et al.
Publicado: (2022)

Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP)
por: Alster, Piotr, et al.
Publicado: (2020)

Gut Microbiota Dysbiosis in Functional Dyspepsia
por: Tziatzios, Georgios, et al.
Publicado: (2020)

Development of the gut microbiota and dysbiosis in children
por: AKAGAWA, Shohei, et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor Levels Correlation with Other Inflammatory Factors in Prognosis of Disability and Death in Patients with Ischemic Stroke
por: Różański, Dorota, et al.
Publicado: (2021)

Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson’s and Alzheimer’s) and Healthy Controls: A Systematic Review
por: Heravi, Fatemah Sadeghpour, et al.
Publicado: (2023)

Oral Dysbiosis and Inflammation in Parkinson’s Disease
por: Fleury, Vanessa, et al.
Publicado: (2021)

Systematic Review on Saliva Biomarkers in Patients Diagnosed with Morbus Alzheimer and Morbus Parkinson
por: Wolgin, Michael, et al.
Publicado: (2022)

Emotional processing in Parkinson’s disease and schizophrenia: evidence for response bias deficits in PD
por: Laskowska, Ilona P., et al.
Publicado: (2015)

Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease
por: Brown, Kirsty, et al.
Publicado: (2012)

The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
por: Baldelli, Valerio, et al.
Publicado: (2021)

Tissue vs. Fecal-Derived Bacterial Dysbiosis in Precancerous Colorectal Lesions: A Systematic Review
por: Valciukiene, Jurate, et al.
Publicado: (2023)

State of the Art of microRNAs Signatures as Biomarkers and Therapeutic Targets in Parkinson’s and Alzheimer’s Diseases: A Systematic Review and Meta-Analysis
por: Zotarelli-Filho, Idiberto José, et al.
Publicado: (2023)

Sex Differences in the Level of Homocysteine in Alzheimer’s Disease and Parkinson’s Disease Patients: A Meta-Analysis
por: Nguyen, V. Phu, et al.
Publicado: (2023)

Gut microbiota and immunity relevance in eubiosis and dysbiosis
por: Al-Rashidi, Hanan E.
Publicado: (2022)

Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson’s Disease
por: Karunaratne, Tennekoon B., et al.
Publicado: (2020)

Machine Learning and Eye Movements Give Insights into Neurodegenerative Disease Mechanisms
por: Przybyszewski, Andrzej W., et al.
Publicado: (2023)

Multimodal Learning and Intelligent Prediction of Symptom Development in Individual Parkinson’s Patients
por: Przybyszewski, Andrzej W., et al.
Publicado: (2016)

The Role of Parkinson Nurses for Personalizing Care in Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: van Munster, Marlena, et al.
Publicado: (2022)

Respiratory-Swallow Coordination in Individuals with Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Rangwala, Rabab, et al.
Publicado: (2023)

Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease
por: Huang, Yiying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_10ttps5s1vla970taqmnk9gjdl